CinCor Pharma, Inc.
CINC
|
NASDAQ
|
3 Sledující
Company Quality
Profitability Score
26/100
Solvency Score
75/100
Dividends
Dividends data currently unavailable.Earnings
Earnings data currently unavailable.My Notes
You haven't added any notes for this stock yet. Use this space to record your insights or strategies.
Profile
Healthcare
Sektor
Biotechnology
Průmysl
Mr. Marc M. P. de Garidel
CEO
19
Zaměstnanci
Boston
Centrála
US
Země
Key Metrics TTM
Valuation
Market cap.
$1.3BEnterprise Value
$1.1BPrice to Earnings
-20.44Price to Sales
0.00Price to Book
-16.15Price to Cash Flow
-41.23Profitability
Return on Assets
-35.68%Return on Equity
110.68%Return on Invested Capital
-34.11%Gross Margin
0.00%Operating Margin
0.00%Net Margin
0.00%Liquidity
Quick Ratio
8.53Current Ratio
8.53Cash Ratio
8.25Inventory Turnover
0.00Asset Turnover
0.00Total Liabilities
$10MSolvency
Debt to Assets
0.00Debt to Equity
N/AInterest Coverage
0.00Equity Ratio
0.98Long-term Debt to Cap.
0.00Altman Z-Score
75.23Performance
Performance data currently unavailable.
Earnings Waterfall
Debt level and coverage
Debt level and coverage data currently unavailable.
Earnings
Feed
There are no posts to show right now.